InMed PharmaceuticalsINM 
$0.282.01%24h
2.01%24h
Global rank36223
Market cap$684.34K
Change 7d-21.71%
YTD Performance-30.13%
SP500 benchmarkUnderperform
P/E-0.09
P/S0.17
Revenue$4.14M
Earnings-$7.95M
Dividend yield-
Main Sector
Healthcare
InMed Pharmaceuticals (INM) Total Liabilities
INM Total Liabilities in 2022: $2.02M
According to InMed Pharmaceuticals latest financial reports the total liabilities of INM is $2.02M, an decrease of -45.63% to 2022. At the end of 2022 company had $3.71M total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that InMed Pharmaceuticals is responsible for during its operational activities.
InMed Pharmaceuticals (INM) Total Liabilities History from 2023 to 2022
-
Value:-
INM Total Liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023 | $2.02M | -45.63% |
| 2022 | $3.71M | 54.24% |
| 2021 | $2.40M | 67.51% |
| 2020 | $1.44M | 59.82% |
| 2019 | $898.18K | - |
View the Top Total Liabilies Stocks
